Can-Fite BioPharma Reports Positive Phase IIa Study Results
Can-Fite BioPharma presents positive Phase IIa data for namodenoson in pancreatic cancer at ESMO 2026, marking a significant step for the company.
GSK Reports Positive Phase I Data for Ovarian Cancer Drug
GSK plc presents encouraging results for Mo-Rez, a new treatment for platinum-resistant ovarian cancer, showing a 62% response rate in phase I trials.
GSK Reports 76% Response Rate for Jemperli in Cancer Trial
GSK plc announces a 76% complete response rate for Jemperli in a rectal cancer trial, marking a potential shift in treatment approaches.
Turkcell announces major share buy-back program
Turkcell Iletisim Hizmetleri A.S. initiates a buy-back of over 3 million shares to strengthen shareholder value and market position.
Dr. Reddy's Laboratories appoints Akhil Ravi as Head API
Dr. Reddy's Laboratories announces the appointment of Akhil Ravi as Head API and Services, effective November 13, 2026, enhancing its leadership team.
BioNTech, DualityBio report Phase 3 trial results for breast cancer
BioNTech SE and DualityBiologics announce topline results from the DYNASTY-Breast02 Phase 3 trial, showing modest benefits for breast cancer treatment.
Sanofi breaks ground on new insulin manufacturing facility
Sanofi has begun construction on a new insulin manufacturing facility in Frankfurt, Germany, to enhance production capacity for diabetes treatments.
111, Inc. Appoints Advisors to Review Strategic Proposal
111, Inc. engages independent advisors to evaluate a strategic proposal, marking a pivotal moment in its transformation within the retail-drug sector.
ICICI Bank receives credit rating reaffirmation from ICRA, CARE
ICICI Bank's credit ratings reaffirmed by ICRA and CARE Ratings, indicating stability in the commercial banking sector and boosting investor confidence.
Nanobiotix Reports Positive Phase 1 Data for Melanoma Therapy
Nanobiotix S.A. announces promising Phase 1 study results for JNJ-1900 (NBTXR3) in anti-PD-1-resistant melanoma, showing a 41.7% response rate.
NetClass Technology to Hold Extraordinary Shareholder Meeting
NetClass Technology Inc. announces an extraordinary general meeting on share consolidation, set for November 10, 2026, in Singapore.
AI OKTO Corp. declares $3.50 special dividend for shareholders
AI OKTO Corp. announces a special dividend of $3.50 per share, payable on November 25, 2026, reflecting strong financial performance.
NovaBridge Biosciences presents new clinical data at ESMO
NovaBridge Biosciences shares new clinical data on ragistomig at ESMO Congress 2026, showcasing advancements in cancer treatment.
AI OKTO Corp. sells LPG carrier Dream Arrax for $18 million
AI OKTO Corp. has sold its LPG carrier, Dream Arrax, for $18 million, focusing on streamlining operations in energy transportation.
Autohome Inc. relocates principal office to Hong Kong
Autohome Inc. announces the relocation of its principal office in Hong Kong, effective immediately, reflecting operational optimization in the tech sector.
Rogers Communications Declares 50 Cents Quarterly Dividend
Rogers Communications announces a quarterly dividend of 50 cents per share, reinforcing financial stability in the cable and pay television industry.
Cementos Pacasmayo Reports Material Event on Tender Offer
Cementos Pacasmayo SAA announces a material event concerning a tender offer for its shares, addressing regulatory comments on share valuations.
BioLineRx Presents Promising GLIX1 Data at ESMO 2026
BioLineRx Ltd. showcases preclinical data for GLIX1, indicating synergy with PARP inhibitors in ovarian cancer at ESMO 2026, signaling a potential shift in treatment strategies.
Ultrapar Holdings reports share sale affecting voting rights
Ultrapar Holdings Inc. announces a share sale that alters voting rights under its Shareholders' Agreement, impacting its shareholding structure.
Embraer reports Q3 2026 results amid industry challenges
Embraer S.A. releases Q3 2026 financial results, showcasing strategies to navigate challenges in the aircraft manufacturing industry.